Narasimharaju SN, senior manager — regulatory affairs and Mac Kella, senior regulatory affairs executive at ELC Group assess whether biosimilars are really interchangeable in the EU.
For coated elastomeric closures, barrier properties alone are no longer enough to meet the needs of biologic drug packaging. Dr Susan Dounce, senior manager, business development and innovation, injection systems, Datwyler Sealing Solutions writes.
BioNTech is a biotech company specialising in lab-to-market immunotherapies. Sean Marett, COO reveals the reasons for his love of biotech and the company’s quest to further advances in this field
Jennifer Mitcham, Catalent Biologics, offers insight into the new generation of antibody drug conjugates and the increasing importance biologics play in the fight against disease
Amit Karpe, 3M explains how it is challenging the traditional clarification process. Using its expertise and technology platforms, the company is approaching it with a different perspective
The European Medicines Agency (EMA) announced on 31 January 2013 that it had released a draft guideline to revise the agency’s current guideline on biosimilars containing low molecular weight heparins (LMWHs), a type of medical product often used...
Biosimilar medicines, one of the fastest growing sectors of the industry, constitute a major share of pharmaceutical expenditure in the EU, the US and globally. From a regulatory perspective, they are a new paradigm in drug development, similarly...
Merck Millipore has launched the Mobius FlexReady solution with Smart Flexware assemblies for tangential flow filtration (TFF). The fully automated system is ready to implement and features scalable filtration technologies for exceptional performance
